5-MeO-DMT Facts
Psychedelic;
Description
5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) — known as "the toad" — is a short-acting psychedelic of the tryptamine class. It activates serotonin receptors in the brain,[1] producing an almost instantaneous dissolution of self and identity.
Subjective effects include rapid ego dissolution, mystical states, intense emotional enhancement, and somatic overwhelm.[2] The experience is defined less by what is seen than by what disappears — self-boundaries collapse into undifferentiated unity, with far less visual complexity than DMT or psilocybin.[2]
5-MeO-DMT produces no physical dependence and has no confirmed lethal dose in humans.[2] The principal danger is pharmacokinetic: blood levels rise disproportionately with dose increases,[3] and combining it with monoamine oxidase inhibitors multiplies exposure several times over, producing dangerous overheating and seizures.[4]
Dose and durationby route · individual sensitivity varies
Starts in 0.08 – 1 minLasts 20 – 40 minAfter-effects 30 – 120 min
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- None
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 2 hours
- Carries over to
- DMT;
psilocybin; LSD; mescaline
Effectslikely at a common dose
- Perception
- Vestibular distortion;
Spatial disorientation; Ganzfeld effect; Holotropic state; Proprioceptive distortion; Sensory deprivation; Brightness alteration; +21 possible, including Visual haze / noise, Visual acuity suppression, Tinnitus - Body
- Spontaneous body sensations;
Body schema distortion; Motor control impairment; Pupil dilation; Vibrations / buzzing; Tingling / electric sensations; Body scan awareness; +33 possible, including Dizziness, Temperature dysregulation, Excessive sweating - Thinking
- Memory suppression;
Cognitive impairment; Thought disorganization; Analysis suppression; Decision impairment; Information processing suppression; Immersion enhancement; Language suppression; Focus suppression; +24 possible, including Suggestibility enhancement, Confusion, Cognitive dysphoria - Feeling
- Emotional enhancement;
Emotional lability; +8 possible, including Anxiety, Dysphoria, Paranoia - Self
- Depersonalization;
Derealization; Social disconnection; Emotional susceptibility; Communication suppression; Sociability suppression; +6 possible - Time
- Time alteration;
Temporal disorientation; Present-moment absorption; +2 possible - Transpersonal
- Unity and interconnectedness
- Awareness
- Personal insight;
Absorption (jhana); +3 possible
Who shouldn't take it
Combinations62 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Glatfelter GC, Clark AA, Cavalco NG, et al. (2024) Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.4c00513
- [2]^abcErmakova AO, Dunbar F, Rucker J, Johnson MW (2022) A narrative synthesis of research with 5-MeO-DMT — Journal of Psychopharmacology doi:10.1177/02698811211050543
- [3]^Shen HW, Jiang XL, Yu AM (2011) Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice — Drug Metabolism and Disposition doi:10.1124/dmd.111.039107
- [4]^Shen HW, Wu C, Jiang XL, Yu AM (2010) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics — Biochemical Pharmacology doi:10.1016/j.bcp.2010.02.020